AdAlta Limited

ASX (AUD): AdAlta Limited (1AD)

Last Price

0.015

Today's Change

0.00 (0.00%)

Day's Change

0.00 - 0.00

Trading Volume

0

Overview

Market Cap

9 Million

Shares Outstanding

631 Million

Avg Volume

351,563

Avg Price (50 Days)

0.02

Avg Price (200 Days)

0.02

PE Ratio

-1.50

EPS

-0.01

Earnings Announcement

25-Feb-2025

Previous Close

0.02

Open

0.02

Day's Range

0.015 - 0.016

Year Range

0.015 - 0.041

Trading Volume

503,220

Price Change Highlight

1 Day Change

-6.25%

5 Day Change

-11.76%

1 Month Change

-21.05%

3 Month Change

-21.05%

6 Month Change

-40.00%

Ytd Change

-40.00%

1 Year Change

-40.00%

3 Year Change

-83.70%

5 Year Change

-88.46%

10 Year Change

-94.45%

Max Change

-94.45%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics in Australia. The company's lead i-body drug candidate includes AD-214, which is in Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. It has collaborative partnerships with GE Healthcare to discover i-bodies that bind to granzyme B; and Carina Biotech Pty Ltd. to develop CAR-T cell products against various solid tumor antigens. AdAlta Limited was incorporated in 2006 and is headquartered in Bundoora, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment